BioCheck, Inc. Acquires DRG International, Inc.
August 18, 2021
BioCheck, Inc. has acquired DRG International, Inc., a manufacturer of clinical diagnostic ELISAs and the DRG:HYBRiD-XL automated analyzer. The deal combines BioCheck's chemiluminescent assay development and automation platform with DRG's R&D, manufacturing and global distribution network to accelerate development and global scale-up of advanced clinical and research diagnostic tests.
- Buyers
- BioCheck, Inc.
- Targets
- DRG International, Inc.
- Industry
- Medical Devices
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Acquires Dynamic Biosensors GmbH
October 2, 2024
Biotechnology
Bruker Corporation has acquired Dynamic Biosensors GmbH, a Munich-based developer of single-cell interaction cytometry and biosensor instruments, to strengthen Bruker’s biosensors portfolio. The deal combines Dynamic Biosensors’ heliXcyto and heliX+ technologies with Bruker’s high-throughput SPR systems to expand capabilities and product offerings for drug discovery and biopharma research; financial terms were not disclosed.
-
Clinical Reference Laboratory Acquires Confirm BioSciences
December 9, 2020
Healthcare Services
Clinical Reference Laboratory (CRL), a large privately held clinical testing laboratory, has acquired Confirm BioSciences, a San Diego–based provider of screening tools and consumer-facing testing products. The acquisition will have Confirm operate as a subsidiary and is intended to expand CRL's lab testing and R&D capabilities while leveraging Confirm's large retail/customer base and COVID-19 testing pipeline.
-
R-Biopharm AG Acquires AusDiagnostics
June 7, 2022
Biotechnology
German biotechnology company R-Biopharm AG has acquired Australian molecular diagnostics manufacturer AusDiagnostics. The purchase adds AusDiagnostics' multiplex MT-PCR platforms, extraction reagents and laboratory automation capabilities to R-Biopharm's clinical diagnostics portfolio, supporting capability expansion and internationalization into new clinical, veterinary and applied testing markets.
-
Calibre Scientific Acquires Dianova GmbH
October 27, 2020
Biotechnology
Calibre Scientific announced the acquisition of Dianova GmbH, a Hamburg-based manufacturer and distributor of antibodies, immunoassays and molecular biology products. Dianova will be integrated into BIOZOL Diagnostica GmbH (a Calibre Scientific subsidiary) to expand product offerings and strengthen distribution across the DACH region (Germany, Austria, Switzerland).
-
Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)
October 4, 2022
Biotechnology
Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.
-
The IMA Group Acquires Diagnostics Research Group
October 12, 2021
Healthcare Services
The IMA Group (IMA) acquired Diagnostics Research Group (DXRG), a San Antonio-based clinical research site, expanding IMA's Clinical Research Division into South Texas and adding DXRG's multi-specialty trial capabilities. Financial terms were not disclosed and DXRG will continue operating under its current name with existing leadership and staff retained.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.